Format

Send to

Choose Destination
Neurosci Biobehav Rev. 2018 Jul;90:16-25. doi: 10.1016/j.neubiorev.2018.03.023. Epub 2018 Mar 30.

Kynurenine pathway in depression: A systematic review and meta-analysis.

Author information

1
Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
2
Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Canada.
3
Keio University School of Medicine, Japan.
4
Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan; Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Canada. Electronic address: piojo629.a6@keio.jp.

Abstract

Abnormalities of the kynurenine (KYN) pathway may be implicated in the pathophysiology of depression. However, the relationships between depression and each metabolite of the KYN pathway remain uncertain. Therefore, we conducted a meta-analysis about the levels of the metabolites of KYN pathway between patients with depression and controls. Out of 899 initial records, we identified 22 articles to form the empirical basis. Seventeen, 10, and 18 studies examined levels of kynurenic acid (KYNA), quinolinic acid (QUIN), and KYN, respectively. KYNA and KYN levels were lower in patients with depression in comparison to controls, while QUIN levels did not differ between the two groups. Antidepressant-free patients showed decreased KYNA levels and increased QUIN levels compared with controls. Male ratios of the samples were negatively associated with study SMDs for KYNA. In conclusion, this meta-analysis revealed that patients with depression had decreased level of KYNA and KYN, whereas antidepressant-free patients showed increased level of QUIN. Nevertheless, given the heterogeneity among their sample characteristics, further research is clearly needed.

KEYWORDS:

Depression; Glutamate; Kynurenic acid; N-methyl-d-aspartate receptor; Neuroinflammation; Quinolinic acid

PMID:
29608993
DOI:
10.1016/j.neubiorev.2018.03.023
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center